Finally, our experiments gave a primarily evidence that SFX-01 impaired tumour growth in both ARMS and ERMS mouse xenografts, as suggested by the reduced tumour volumes and weights obtained from SFX-01 treated mice compared to negative control animals. Here, KIDINS220 is linked to neoplasm.